Summary
Background
Public Health England (PHE) developed an antimicrobial stewardship (AMS) surveillance
system and conducted a national pilot to test the feasibility of centrally collecting
data from AMS audits performed by NHS hospital trusts. The system was simplified,
focusing on requirements of the NHS AMR CQUIN (Commissioning for Quality and Innovation;
a financial incentive quality improvement scheme).
Aim
To present results and user feedback from the national pilot, and results from using
the AMS surveillance system as part of the AMR CQUIN.
Methods
An AMS surveillance system was developed and a national pilot conducted in which 33
NHS trusts submitted data and feedback on system utilization. The system was refined
based on feedback and deployed nationally to collect AMS data for the 2016–17 AMR
CQUIN.
Findings
Most trusts participating in the pilot collected data on documentation of indication
(90%). Fewer collected data on documenting review decisions at 48–72 h (36%). On average
83% of patients had an indication documented, whereas 71% had formal documentation
of 48–72 h review. AMR CQUIN data were submitted by 88% of trusts for at least one
quarter of 2016–17. Approximately 92% of prescriptions had an indication documented
and 87.5% of prescriptions had evidence of review within 72 h; these increased by
7 and 10 percentage points respectively between the first and final quarters.
Conclusion
The AMS surveillance system allowed AMS audit data from NHS trusts in England to be
collected centrally. PHE publishes these data openly online, on PHE Fingertips portal,
a national public health data portal. The reported data highlight improvement in the
percentage of antibiotic prescriptions with evidence of a documented review within
72 h.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Hospital InfectionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart – Then Focus.J Antimicrob Chemother. 2012; 67: i51-i63
- Implementation of antimicrobial stewardship interventions recommended by national toolkits in primary and secondary healthcare sectors in England: TARGET and Start Smart Then Focus.J Antimicrob Chemother. 2016; 71: 1408-1414
National Center for Health and Care Excellence, NICE Guideline [NG15]. Antimicrobial Stewardship: systems and processes for effective antimicrobial medicine use.
World Health Organization. Public health surveillance. Available at: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/en/[last accessed October 2020].
- Updated guidelines for evaluating public health surveillance systems; recommendations from the Guidelines Working Group.2001
- Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR).J Antimicrob Chemother. 2013; 68: 2421-2423
- UK five year antimicrobial resistance strategy 2013–2018.2013
- Anti-microbial resistance (AMR) CQUIN 2016/17 2016.(Available at:) ([last accessed October 2020])
- Antimicrobial stewardship: an evaluation of structure and process and their association with antimicrobial prescribing in NHS hospitals in England.J Antimicrob Chemother. 2019; 74: 1143-1152
- Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips.J Antimicrob Chemother. 2017; 72: 953-956
- Reducing the impact of serious infections CQUIN 2017/19.2017 (Available at:) ([last accessed October 2020])
- Antimicrobial resistance CQUIN 2019/20.2019 (Available from:) ([last accessed October 2020])
- Behaviour change and antibiotic prescribing in healthcare settings: literature review and behavioural analysis.2015 (Available at:) ([last accessed October 2020])
- AMR local indicators, PHE Fingertips Portal.(Available at:) ([last accessed October 2020])
- English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report 2018–2019.(Available at:) ([last accessed October 2020])
Article info
Publication history
Published online: October 26, 2020
Accepted:
October 21,
2020
Received:
July 31,
2020
Identification
Copyright
Crown Copyright © 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. All rights reserved.
